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Abstract
Summary We hypothesized that combining clinical risk
factors (CRF) with the heel stiffness index (SI) measured
via quantitative ultrasound (QUS) would improve the
detection of women both at low and high risk for hip
fracture. Categorizing women by risk score improved the
specificity of detection to 42.4%, versus 33.8% using CRF
alone and 38.4% using the SI alone. This combined CRF-SI
score could be used wherever and whenever DXA is not
readily accessible.
Introduction and hypothesis Several strategies have been
proposed to identify women at high risk for osteoporosis-
related fractures; we wanted to investigate whether com-
bining clinical risk factors (CRF) and heel QUS parameters
could provide a more accurate tool to identify women at
both low and high risk for hip fracture than either CRF or
QUS alone.
Methods We pooled two Caucasian cohorts, EPIDOS and
SEMOF, into a large database named “EPISEM”, in which
12,064 women, 70 to 100 years old, were analyzed.
Amongst all the CRF available in EPISEM, we used only
the ones which were statistically significant in a Cox
multivariate model. Then, we constructed a risk score, by
combining the QUS-derived heel stiffness index (SI) and
the following seven CRF: patient age, body mass index
(BMI), fracture history, fall history, diabetes history, chair-
test results, and past estrogen treatment.
Results Using the composite SI-CRF score, 42% of the
women who did not report a hip fracture were found to be
at low risk at baseline, and 57% of those who subsequently
sustained a fracture were at high risk. Using the SI alone,
corresponding percentages were 38% and 52%; using CRF
alone, 34% and 53%. The number of subjects in the
intermediate group was reduced from 5,400 (including 112
hip fractures) and 5,032 (including 111 hip fractures) to
4549 (including 100 including fractures) for the CRF and
QUS alone versus the combination score.
Conclusions Combining clinical risk factors to heel bone
ultrasound appears to correctly identifymore women at low risk
for hip fracture than either the stiffness index or the CRF alone;
it improves the detection of women both at low and high risk.
Keywords Clinical risk factors . Hip fracture .
Osteoporosis . Quantitative ultrasound . Risk score
Introduction
Osteoporosis is a major public health problem. There are an
estimated 9.4 million postmenopausal white women (i.e.,
30% of all white women ≥50 years of age) with osteo-
porosis in the United States [1], leading to more than
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250,000 hip fractures annually [2–5], at least 90% of which
occur in women ≥70 years of age [6, 7]. One in every six
white women will sustain a hip fracture during her lifetime
[8, 9]. Hip fractures are responsible for an increased risk of
mortality, increasing the 5-year mortality rate by about
20%. They also produce considerable morbidity, with many
patients suffering from severe and often persistent physical
and social limitations [6, 10–15].
Dual X-ray absorptiometry (DXA) is the current gold
standard to predict fractures. However, due to high costs,
stringent reimbursement criteria, and a lack of awareness
and available DXA devices in certain geographical parts of
the world, only a small percentage (from approximately
20% to 30%) of women with osteoporosis are diagnosed
using DXA [16, 17]. In instances wherein DXA is
unavailable or not readily accessible, other methods –
either historical, as in the use of clinical risk factors (CRF),
or quantitative, as in quantitative ultrasound (QUS) of the
heel – might be used as a surrogate method to identify
women both at low and high risk for hip fracture. Indeed,
numerous studies have shown that heel QUS is a strong
predictor of hip fracture [18–26]. Similar findings have
been reported for CRF [22, 27–37]. However, there are no
existing guidelines pertaining to the clinical use of QUS.
Nonetheless, one could foresee several scenarios in which
QUS might be used:
– Detecting women at very high risk for fracture, using a
single threshold
– Detecting women at very low risk for fracture, using a
single threshold; thereby avoiding further examination
– Detecting both women at very high risk and women at
very low risk for fracture, using two thresholds;
women in neither category (those at moderate risk)
would be referred for further examination.
In addition, heel QUS and CRF predict hip fracture
independent of each other [22, 27–37]. Therefore, the
previous scenarios could be performed combining heel
QUS and CRF, likely improving the predictive power of
either instrument used alone. However, to date, only two
published studies have addressed this question. Porter et al.
combined the broadband ultrasound attenuation (BUA) and
cognizance testing into a risk score [23]. They found that
the incidence of hip fracture was 12.8% in the high risk
(low BUA index and cognizance score) group, versus 1.5%
in the lowest risk (high BUA index and cognizance score)
group. Dargent-Molina et al. defined three specificity
cutoffs (50%, 25% and 10%)[22]. They found that adding
age to calcaneal BUA in a risk score increased sensitivity
relative to using each parameter alone. Adding gait speed to
the BUA improved sensitivity, but this increase was
significant only at the 25% cutoff and relative to gait speed
alone. These two studies focused only on those at high risk.
At a recent conference, Krieg et al. proposed a risk score
based upon a linear combination of QUS and CRF, for use
in the prediction of non-vertebral fracture risk [38].
Using a very large database, we took the next step,
determining both a high-risk and a low-risk threshold,
thereby identifying three categories of women (high-risk,
moderate risk, and low-risk), and setting conditions for
sensitivity or specificity during the construction of the two
thresholds in order to compare QUS alone, CRF alone, and
QUS and CRF used together. We hypothesized that
combining heel QUS and CRF would improve the detection
of women both at low and high risk for hip fracture. Our
goal was to assess whether this easy-to-use composite risk
score improves hip fracture detection in a large, population-
based database.
Materials and methods
Study population
We pooled two large prospective cohorts of Caucasian
women, EPIDOS and SEMOF, to generate a larger
database, called ‘EPISEM’. This was feasible because of
the similarity of the questionnaires on osteoporosis CRF
used during data collection, the risk factors investigated, the
measurement techniques used, and the study populations.
The following are details about the two original databases:
(1) EPIDOS (EPIDemiology of Osteoporosis): This was a
cohort of French 7,598 women age 75 and over,
enrolled in a multi-centre prospective study on hip
fracture risk factors [18, 39]. Women who had
undergone a bilateral hip replacement or had previ-
ously suffered a hip fracture were excluded. From the
EPIDOS study, we only used baseline data from the
questionnaires, tests for osteoporosis, and the heel
stiffness index (SI), determined using QUS (Achilles,
GE-Lunar Corp.). QUS measures the speed of sound
(SOS, in m/s) and the degree of attenuation of the
ultrasound (BUA, in dB/MHz), so as to calculate a SI
(%), which is a combination of BUA and SOS (SI=
(0.66× BUA) + (0.28× SOS) - 416.7) [40, 41]. Only
5,896 women in the database had undergone heel QUS
and had non-outlier values for DMO by DXA and for
SI by QUS. The survey instrument included questions
or test instruments to collect data on anthropometric
indices, behavior, health conditions/states, gynecologic
state, fracture/treatment/fall history, simple function,
and mental status. Women were followed for an
average of 3 years, during which time, hip fracture
occurrence and state/condition changes were deter-
mined every 4 months.
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(2) SEMOF (The Swiss Evaluation of the Methods of
Measurement of Osteoporotic Fracture Risk): This was
a cohort of 7,062 Swiss women, 70 years and over, who
were enrolled in a prospective multi-centre study
comparing three heel QUS devices in the assessment
of hip fracture risk [42]. From the SEMOF study, we
used only baseline data from the questionnaires/tests
for osteoporosis CRF, and the heel SI as determined
by QUS (Achilles, GE-Lunar Corp.). The survey
instrument included questions or test instruments to
collect data on anthropometric indices, behavior,
health conditions/states, gynecologic status, fracture/
treatment/fall history, and simple function. As for the
EPIDOS sample, all subjects had been followed for an
average of 3 years to identify incident hip fractures.
Consequently, the EPISEM database consisted of 12,958
women, 7,062 from SEMOF and 5896 from EPIDOS.
However, due to missing values, we used a sample of
12,064 women Among all the CRF variables available in
the EPIDOS and SEMOF studies, only 22 were retained for
the EPISEM database, in accordance with our previously-
published review article [43]; this article allowed us to
select the CRF deemed most significant for hip fracture risk
in prospective studies. Furthermore, we focused on factors
related to bone. Finally, only variables available both in
EPIDOS and SEMOF were used. These variables were age,
height, weight, body mass index (BMI), heel stiffness
index, prior history of fracture, prior history of fall, prior
exposure to estrogen, current exposure to estrogen, chair
test success, current diabetes, high level of education,
sedentary lifestyle, current smoking, prior smoking, past
glucocorticoid use lasting at least 3 months, current
glucocorticoid use, maternal history of hip fracture, early
menopause, surgical menopause, current thyroid hormone
treatment, and parity (parous versus nulliparous).
Quality control procedures were conducted to assess the data
gleaned from the two studies, which included in vitro and in
vivo precision as well as cross-calibration between QUS
devices, as described elsewhere [18, 42, 44]. Cross calibration
between studies also was performed (data not published).
Statistical analysis
Baseline characteristics of the EPISEM sample were
expressed as means and standard deviations (SD) for
continuous variables, and as percentages for categorical
variables. Inter-group comparisons, between the fracture
and non-fracture groups, were conducted with p<0.05 set
as the threshold for statistical significance.
Initial univariate analysis consisted of Cox regression to
identify risk factors that were statistically associated with
hip fracture. As a second step, Cox multivariate analysis
was performed, using backward stepwise selection, retain-
ing variables at a 5% level of significance. All possible
interactions between variables were examined. Cox analysis
by STATA, in turn, generated hazards ratios (HR).
With respect to continuous variables, no transformation
was performed for age, height or weight. BMI, on the other
hand, was stratified into a categorical variable, consisting of
three categories: <26, C26–31C, and ≥31. In addition,
because no accepted thresholds exist for heel QUS, we
used the high and low-risk thresholds for SI defined by
Hans et al.: 59.1 and 77.6, respectively [45].
A primary model was generated to represent a risk score
combining the stiffness index and clinical risk factor values.
This combined SI-CRF score was compared with the risk
score comprised of CRF data alone, and the risk score
comprised of the SI plus the patient’s age.
The variable ‘cohort’ was entered into the Cox model to
prevent potential heterogeneity, but the corresponding β
coefficient (calculated from the corresponding HR generat-
ed by STATA) was not included in the score. To adjust for
bias introduced by using the same patient data to both
generate and validate the score, we used the bootstrapping
tool provided in STATA to assess the stability of each
model; this bootstrapping step demonstrated that the
coefficients in the multivariate model were statistically
significant, and that the model was stable.
We constructed three Cox multivariate models, using (1)
the heel stiffness index plus the patient’s age; (2) the
clinical risk factors deemed significant (p≤0.05) on
univariate analysis; and (3) the stiffness index, age and
the CRF selected in model 2. We converted each final
multivariate Cox model into a simple additive risk score,
using the β coefficient (calculated from the corresponding
HR) for each independent predictor, thereby weighting each
variable relative to its influence on hip fracture risk. To
generate integer-valued additive factors, we multiplied β by
10 and rounded the result to the nearest full digit to obtain
risk points. The final SI-age score was constructed using a
linear combination of the class value weighted by the
associated risk points. For the categorical variables, we
have attributed to each class a integer (0 vs. 1 or 1 vs. 2).
We have named this integer value the “class value”.
For the risk score based upon CRF alone, we evaluated
the potential effect of variables previously found non-
significant on univariate analysis.
For each of the 3 risk scores, we determined two thresholds
(high and low-risk), utilizing the approach described by Hans
et al. [45]. The application of these thresholds to the database
determined, for each score, three categories of women: those
at low, intermediate and high risk for hip fracture. For each
of the 3 scores, a ‘high risk’ threshold was defined as the
value of the score corresponding to a specificity of 80%.
Using this threshold, performance indicators were: (1)
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sensitivity (the percentage of women defined at high risk at
baseline among those who ultimately sustained a fracture);
(2) positive predictive value (PPV, the percentage of women
at high risk who sustained a fracture); and (3) 100%-PPV
(the percentage of women at high risk who failed to develop
a fracture, a group that represents those women who were
treated inappropriately).
For the ‘low-risk’ threshold (corresponding to a sensi-
tivity of 90%), we measured three other indicators: (1)
specificity (the percentage of women defined at low risk at
baseline among those without fractures); (2) negative
predictive value (NPV, the percentage of women deemed
to be at low risk who did not sustain a fracture); and (3)
100%-NPV (the percentage of women deemed to be at low
risk who actually sustained a fracture, which represents the
percentage of women who should have been treated).
All statistical analyses were performed using the
statistical software package, STATA version 8.2.
Results
Baseline characteristics for the 12,064 women between 70
and 100 years old in the EPISEM database are shown in
Table 1. During a mean follow-up period of 3.2±0.9 years,
307 hip fractures were observed, for an incidence rate of
7.32 per 1,000 woman-years.
In the univariate Cox model, several factors were
associated with hip fracture at the 5% significance level.
They were patient age, low height, low weight, low BMI,
low stiffness index, a prior history of fracture, a prior
history of a fall (within the past year), no prior or current
exposure to estrogen, chair test failure, the presence of
diabetes, and a sedentary lifestyle (Table 1).
Risk score based upon SI and age
The variables entered in the multivariate Cox model were
age, as a continuous variable, and stiffness index, as a
categorical variable (≤59.1; ]59.1–77.6 [; ≥77.6) [45]; these
variables all were significant at the 5% level. No interaction
term was statistically significant. To calculate the risk score
for each woman, the number of points associated with each
indicator was multiplied by the corresponding class value
(Table 2). The final score was obtained easily as the sum of
these weighted points. For example, a 82-year-old woman
with a stiffness index of 74 had a risk score of (12×1) +
(1×7) = 19. Even though the maximum possible score was
Table 1 Characteristics of baseline variables in the EPISEM sample (n=12,064)
Non-hip-fracture group Hip-fracture group Univariate Cox model
Mean ± SD % Mean ± SD % P-value* HR** (95% CI)
Age 77.6±4.3 81.0±4.8 0.0000 1.16 (1.13–1.18)
Height 156.3±6.5 155.0±6.8 0.0015 0.98 (0.96–0.99)
Weight 62.7±11.2 58.98±9.8 0.0000 0.97 (0.96–0.98)
BMI 25.7±4.3 24.5±3.8 0.0000 0.94 (0.91–0.97)
Stiffness index 68.9±13.5 59.7±12.6 0.0000 0.94 (0.93–0.95)
Prior history of fracture 48.3 55.9 0.0105 1.38 (1.10–1.75)
Prior history of fall 27.7 33.6 0.0286 1.36 (1.06–1.73)
Prior exposure to estrogen*** 18.1 12.2 0.0107 1.65 (1.16–2.36)
Current exposure to estrogen*** 8.1 4.2 0.0166 1.87 (1.05–3.33)
Chair test succeed*** 90.9 78.7 0.0000 2.82 (2.13–3.75)
Presence of diabetes 5.8 9.4 0.0093 1.76 (1.18–2.62)
High education 9.9 14.3 0.0131 1.31 (0.94–1.83)
Sedentary 37.3 53.5 0.0000 1.77 (1.40–2.24)
Current smoking 5.5 6.0 ns 1.18 (0.72–1.92)
Already smoked 18.4 15.1 ns 0.86 (0.62–1.19)
Glucocorticoids 3 months in past 5.0 6.4 ns 1.23 (0.77–1.99)
Current glucocorticoids 2.4 2.8 ns 1.25 (0.62–2.53)
Maternal hip fracture 8.6 8.7 ns 1.02 (0.67–1.53)
Early menopause 13.6 16.8 ns 1.24 (0.91–1.69)
Surgical menopause 19.0 15.7 ns 0.82 (0.60–1.13)
Current thyroid hormone treatment 4.6 3.8 ns 0.87 (0.47–1.58)
Parous 77.5 79.7 ns 1.13 (0.85–1.51)
HR: Hazard ratio; ns: non significant
* Comparison between the hip-fracture group and the non-hip-fracture group
** per 1 unit variation for continuous variables or yes versus no for categorical variables except for *** where HR is no versus yes
1654 Osteoporos Int (2007) 18:1651–1659
62 [(30×1) for age=100, and (2×16) for a stiffness index
≤59.1], the maximum score observed in the study popula-
tion was 44. Based upon the sensitivity and specificity
criteria mentioned earlier, the ‘low-risk’ threshold was set at
12 and the ‘high risk’ threshold at 23.
Risk score based upon CRF alone
The variables that were entered into the Cox model were
age as a continuous variable, BMI as a categorical variable
(≥31; C26–31C; and <26), and several binomial variables:
prior history of fracture, prior history of fall, no prior
exposure to estrogen, chair test failure (failure to stand up at
least 2 times from a chair without arms), presence of
diabetes, and cohort (Table 2). No interaction term was
statistically significant.
The score was determined by weighting variables, as
previously described. For example, an 82-year-old woman
with a BMI of 30, who already had sustained a fracture, had
fallen, took oestrogen, failed the chair-test, and has diabetes
would have a score of [(12×1) + (1×6) + (1×4) + (1×3) + 0 +
(1×8) + (1×7)] =40. Even though the maximum possible score
was 76 [(30×1) points for age=100, (2×10) for a BMI <26,
(1×4) for a prior history of fracture, (1×3) for a prior history of
fall, (1×4) for not having taken estrogen treatment in the past,
(1×8) for failing the chair-test, and (1×7) for diabetes], we
observed a maximum of 54 in the study population. The ‘low-
risk’ threshold was set at 19 and the ‘high-risk’ threshold at 28.
Table 2 For the prediction of hip fracture, the hazard ratio per standard deviation change (or class change for categorical parameters) for each
parameters included into a multivariate Cox model corresponding to the three 3 risk scores are reported (SI plus age; clinical risk factors alone;
and combining SI and clinical risk factors)
Predictor HR in the score based
on SI and age*
Risk
points
HR in the score
based on CRF*
Risk
points
HR in the score
combining SI and CRF*
Risk
points
Class
value
Age (per 1 year
increase from 70)
1.1 (1.1–1.2) 1 1.1 (1.1–1.1) 1 1.1 (1.1 –1.1) 1 /
BMI
C26–31C / / 1.8 (1.0–3.2) 6 1.8 (1.0–3.3)a 6 1
<26 / / 2.6 (1.5–4.5) 10 2.3 (1.3–3.9)a 8 2
Prior history of fracture
(yes vs. no)
/ / 1.4 (1.1–1.8) 4 1.3 (1.0–1.6) 2 1
Prior history of fall
(yes vs. no)
/ / 1.4 (1.1–1.7) 3 1.4 (1.1–1.8) 3 1
Prior exposure to
estrogen (no vs. yes)
/ / 1.5 (1.1–2.2) 4 1.5 (1.1–2.1) 4 1
Chair test success
(no vs. yes)
/ / 2.3 (1.7–3.0) 8 2.1 (1.5 –2.8) 7 1
Presence of diabetes
(yes vs. no)
/ / 2.0 (1.3–2.9) 7 2.3 (1.5–3.5) 8 1
Stiffness index
]59.1–77.6[ 2.1 (1.3–3.3) 7 / / 2.1 (1.3–3.3)b 7 1
<=59.1 4.9 (3.1–7.7) 16 / / 4.5 (2.8–7.1)b 15 2
HR: hazard ratio; SI: stiffness index; CRF: clinical risk factors; vs.: versus
*(95% Confidence Interval)
a : reference class : BMI >=31
b : reference class : stiffness index >=77.6
In addition the value attributed to the different class or risk are also mentioned.
Table 3 Comparative performance of the three risk scores (SI plus age; clinical risk factors alone; and combining SI and clinical risk factors) in
the detection of women at high risk for hip fracture, using the high-risk threshold corresponding to a specificity ∼80%
Strategies
Parameter (95% CI) Score based on SI and age Score based on CRF Score combining SI and CRF
sensitivity 51.7 (45.8–57.7) 52.8 (46.8–58.7) 57.0 (51.0–62.8)
PPV 6.0 (5.1–7.0) 5.7 (4.8–6.6) 6.5 (5.6–7.6)
1-PPV 94.0 (93.0–94.9) 94.3 (93.4–95.2) 93.5 (92.4–94.4)
CI: confidence interval; SI: stiffness index; CRF: clinical risk factors; PPV: positive predictive value
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Risk score combining SI and CRF
The variables entered into the multivariate Cox model were
age as a continuous variable, BMI as an ordinal categorical
variable (≥31; C26–31C; and <26), the stiffness index as
an ordinal categorical variable (≤59.1; ]59.1–77.6[; and
≥77.6) and several binomial variables: prior history of
fracture, prior history of a fall, no prior exposure to
estrogen, chair test failure, diabetes, and cohort. These
variables all were significant at the 5% level, and were
retained in the final multivariate Cox model (Table 2). No
interaction term was statistically significant.
The composite score was determined as previously
described. The maximum possible score was 100, but the
maximum observed in the database was 64. The ‘low-risk’
threshold was set at 25 and the ‘high-risk’ threshold at 36.
Using these two thresholds, 42% of the women were
classified in the low-risk group (5,012 women), 21% in the
high-risk group (2,503 women) and 38% in the intermedi-
ate-risk group (4,549 women).
Detection of women at high risk for hip fracture
Using the high-risk threshold, we show the values for the
three indicators (sensitivity, PPV and 1-PPV) in Table 3.
The composite score, combining SI and CRF, seemed to
yield the best results for all indicators. With respect to PPV
and 1-PPV, the score based upon CRF alone seemed to
generate the least satisfactory results. The composite score
produced a sensitivity of 57%, versus 51.7% for the SI-age
score and 52.8% for the score based on CRF alone; among
the fractured women, the composite score identified 163
women at high risk, 12 more than using CRF alone (151)
and 15 women more than using the score comprised of SI
plus age (148).
Detection of women at low risk for hip fracture
Using the low-risk threshold, we show the values for the
three indicators (specificity, NPV, and 1-NPV) in Table 4.
The score combining SI and CRF yielded the best results,
but the SI + age score and the score based on CRF alone
did produce correct values. The score based upon CRF
alone seemed to be the least specific. NPV and 1 - NPV
were identical with CRF alone versus SI + age alone. The
composite SI-CRF score correctly identified approximately
9% more women at low risk for hip fracture than CRF
alone (specificity of 42.4% versus 33.8%) and 4% more
women than the SI + age score (42.4% versus 38.4%);
among the women without fractures, the composite score
identified 4,989 women at low risk, 465 women more than
using the SI + age score (4,524) and 1,008 more than using
CRF alone (3,981).
The areas under the receiver operating characteristic
(ROC) curve were 0.729 (0.701–0.759), 0.746 (0.718–
0.774) and 0.762 (0.735–0.789) for CRF alone, SI + age,
and SI + CRF, respectively (Fig. 1). Using chi-square
analysis, statistically-significant differences were identified
between the areas under the ROC curves, both between SI +
age and SI + CRF (p<0.001) and between CRF alone and SI +
CRF (p<0.001), but not between SI + age and CRF alone.
Discussion
In a large cohort of over 12,000 Caucasian women, derived
from two prospective cohorts of Europeans, we found that a
simple additive risk score combining the stiffness index (SI)
and easily-assessed CRF (patient age, BMI, prior history of
Table 4 Comparative performance of the three risk scores (SI plus age; clinical risk factors alone; and combining SI and clinical risk factors) in
the detection of women at low risk for hip fracture, using the low risk threshold corresponding to a sensitivity ∼90%
Strategies
Parameter (95% CI) Score based on SI and age Score based on CRF Score combining SI and CRF
specificity 38.4 (37.5–39.3) 33.8 (32.9–34.7) 42.4 (41.5–43.3)
NPV 99.4 (99.1–99.6) 99.4 (99.1–99.6) 99.5 (99.3–99.7)
1-NPV 0.6 (0.4–0.9) 0.6 (0.4–0.9) 0.5 (0.3–0.7)
CI: confidence interval; SI: stiffness index; CRF: clinical risk factors; NPV: negative predictive value
Fig. 1 Receiver operating characteristic (ROC) curves for the 3 risk
scores (SI plus age; clinical risk factors alone; and combining SI and
clinical risk factors). SI: stiffness index; CRF: clinical risk factors
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fracture, prior history of fall, no prior exposure to estrogen,
chair test failure, and the presence of diabetes) was able to
improve the detection of women at both low and high risk
for hip fracture, relative to SI or CRF alone. This composite
score improved specificity by 4%, corresponding to 465
additional women correctly identified, and up by 9%,
corresponding to 1,008 additional women correctly identi-
fied, relative to the SI + age score and the score for CRF
alone, respectively. It improved sensitivity by 4%,
corresponding to 12 additional women, and by 5%,
corresponding to 15 additional women, relative to the score
for CRF alone and the SI + age score, respectively. The
composite score also tended to improve hip fracture
prediction (PPVof 6.5% versus 6.0% and 5.7%), decreasing
the number of women unnecessarily treated. Another
positive aspect of the combination is the decrease of
number of subjects in the intermediate group. Indeed, this
number was reduced from 5,400 (including 112 hip
fractures) and 5,032 (including 111 hip fractures) to 4,549
(including 100 including fractures) for the CRF and QUS
alone versus the combination score.
On one hand, clinical risk factors are cheap and quite
predictive; but, on the other hand, can one truly justify treating
or not treating patients on the basis of qualitative parameter
only? Indeed, prior initiating a treatment it is usually very
reassuring to have quantitative information on the bone. In
addition QUS is an inexpensive and effective measurement
tool that is covered by many insurance policies. Comparing
the cost of such a technique and the clinical outcome of the
combination (adding SI to CRF), this approach would be
likely cost-effective assuming that patients identified at very
low or very high risk of fracture do not need any further DXA
examination. In addition we have seen that adding SI to CRF
will better classify the number fo subject in the intermediate
group (moderate risk). Indeed about 900 subjects initially
classified into this “grey zone” have been re-assigned to either
high or low risk group demonstrating apparently a cost
effective gain of this approach.
Similar findings but to lesser extend have been found for
QUS users. Adding CRF to SI in a composite score is
obviously a cost-effective advantage. Indeed, by just asking
seven easy to ask questions, the predictive power of QUS is
significantly improved (specificity and sensitivity). There-
fore it would be recommended to use CRF in conjunction of
QUS measurement. In addition for those who are still
doubtful about the use of QUS in the management of
osteoporosis, combining CRF with QUS would enhance
positively the degree of confidence. Again the number of
subjects in the intermediate group has been reduced by about
500 (including 11 hip fractures), meaning that these patients
have been re-classified to either low or high risk group.
In both scenarios (CRF + SI or SI + CRF) for low-risk wom-
en, we propose a reexamination after 5 years corresponding
approximatively to the monitoring time interval [45]. Accord-
ing to our proposed strategy, those 38% of women deemed to
be at the moderate-risk, who comprise what we would call an
‘osteopenic group’ if we were using DXA and the WHO
definition, would have a DXA examination when available;
otherwise, alternative management should be considered (e.g.,
nutrition, exercise, followed by re-examination after two
years). It is important to remember that the risk score we
propose predicts hip fracture relative to a gradient of risk,
which has nothing to do with the classification of osteoporosis
as in the WHO definition.
It is difficult to compare our results with those reported
by other papers in the field, because our review of the
literature demonstrated that strategies focusing on hip
fractures in women either combine DXA and CRF (with
or without QUS), DXA and QUS, or bone markers and
DXA (and/or QUS) [43]. Combining QUS and CRF has
been studied in the context of other kinds of fracture. The
only two studies that assessed the combination of QUS and
CRF for hip fractures in women both used very different
CRF and BUA, and neither used the stiffness index as the
QUS parameter [22, 23].
The risk score using two thresholds allowed detection of
both low-risk and high-risk women. In practice, further
issues need to be addressed. What should be done with
high-risk women? What should be done with low-risk
women? With women at moderate risk? Our approach
would mean treating high-risk women on the basis of a low
QUS value (and the presence of some CRF) without further
confirmation. A key challenging question is whether
individuals identified by QUS as “high risk” for fracture
will benefit significantly by treatment with antiresorptive
agents or other medications. Currently, there are no
randomized double blinded, placebo control clinical trials
showing reduction of fracture risk in patients selected for
treatment according to QUS measurement. However, as
stated by Glüer, there are good reasons to believe that these
patients would benefit from approved osteoporosis medi-
cations; indeed, the primary effect of these medications is in
improving bone strength, and heel QUS have been shown
to reflect femoral bone strength [46].
Admittedly, our study has limitations. The first deals
with the issue of generalizability. Because all the women in
the study were volunteers, Caucasian and living indepen-
dently at home, our results may not be applicable to less
mobile, less healthy elderly women, such as nursing-home
residents, or to Eurasian and black women. In addition,
since the EPISEM population only included women who
were 70-years old and over, our results may not be
extrapolated to a large population of younger women, or
to men. Second, the risk factors we included in our models
were limited to those both easily-accessed and measured in
the EPISEM study population. Other risk factors reported in
Osteoporos Int (2007) 18:1651–1659 1657
the literature might improve the performance of the risk
score [43]. From a QUS prospective, it is well know that
QUS parameters can predict hip fracture equally well than
DXA [43]. However results for one device may not be
extrapolated to another one technologically different.
Therefore our results are device specific, although we
believe that any other well validated heel ultrasound device
will end up with similar results.
In conclusion, we have developed an additive composite
risk score to assess the risk of hip fracture in older
postmenopausal Caucasian women using specific thresholds.
This score, which combines the heel stiffness index (SI), as
measured by QUS, and a set of easily-determined clinical
risk factors, appears to be more sensitive and specific than
either the SI or CRF used alone, in terms of detecting
women at low risk and women at high risk for hip fracture
over 3 years. In addition, this composite score does not
require supplementary time or costs and is not associated
with any ionizing radiation exposure. As such, we believe
that it may be useful in both the initial detection and ultimate
management of osteoporosis among postmenopausal wom-
en, especially in terms of reducing health care costs, and in
communities wherein DXA is not readily accessible. The
combined SI-CRF / CRF-SI potential also could eliminate
the costs incurred by performing DXA examinations on both
low and high risk group. Subsequently only 38% of elderly
post-menopausal women who are at intermediate risk of hip
fracture (4549) would need a DXA examination if available.
Additional models currently are under investigation (differ-
ent thresholds and methodology) as well as a cost-effective
analysis.
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